StirlingCollies

 

 (Diane Stirling - Working Collie Breeder in Minnesota)

 

ALL NORMAL EYED, NON-CARRIER FOR PRA and Normal Eyed for CEA,

Many Non-Carrier for CEA

Rough Coat Collies and Smooth Coat Collies

 

 

Stirling's Vennessee-Fantasys Selina - "Selina" - Normal Eyed, Non-Carrier for PRA, Normal Eyed for CEA (paperwork available upon request)

Blue Ridge Son-Of-A-Gunnin' X Hickory Creeks Midnight Moon

Stirlingcollies - blue merle collie
Stirlingcollies - blue merle collie
Stirlingcollies - blue merle collie
Stirlingcollies - blue merle collie

Selina

Stirlingcollies - blue merle collie
Stirlingcollies - Selina pedigree

DNA Test Completed October 09, 2012
Registered Name: Stirling's Vennessee-Fantasys Selina
Call Name: Selina
Breed: Collie
Gender: Female
Optigen Accession #: 12-8279
Test Performed: Rod-Cone Dysplasia Type 2
Sample Type: Swab
Test Results: Genotype of Dog tested is Normal
Risk for developing rcd2 form of PRA: Will never develop rcd2 form of PRA.
Significance for breeding: Can be bred to any dog and will produce no pups affected by rcd2 form of PRA.
This interpretation is based on the test result of the DNA test for the specific mutation identified as causing the rcd2 form of PRA in Collies as of the date on this report.
For further information, please visit OptiGen's website at www.optigen.com.

 

DNA Test Completed October 04, 2012
Registered Name: Stirling's Vennessee-Fantasys Selina
Call Name: Selina
Breed: Collie
Gender: Female
Optigen Accession #: 12-8279
Test Performed: CEA/CH test
Sample Type: Swab
Test Results: Genotype of your dog is CARRIER.
Risk for developing Collie Eye Anomaly/Choroidal Hypoplasia (CEA/CH): This dog will never develop CEA/CH.
Significance for breeding: This dog should only be bred to a mate of normal CEA/CH genotype in order to avoid producing pups affected with CEA/CH.
This interpretation is based on the test result of the DNA test for the specific mutation identified as causing CEA/CH in Collies as of the date on this report.
For further information, please consult the OptiGen website at www.optigen.com.